FibroGen Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
84.33 M |
Public Float |
78.19 M |
FibroGen Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.08 |
Market Cap |
$3.82 B |
Shares Outstanding |
86.15 M |
Public Float |
75.13 M |
Address |
409 Illinois Street San Francisco California 94158 United States |
Employees | - |
Website | http://www.fibrogen.com |
Updated | 07/08/2019 |
FibroGen, Inc. engages in the discovery, development, and commercialization of therapeutics to treat unmet medical needs. It focuses on fibrosis and hypoxia-induced factor biology to generate programs targeting therapeutic areas. The company was founded by Thomas B. |